KR 最新10-Q变化
将 KR 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-09-18 与上一份 10-Q · 2026-06-26
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +60 | −32 | ~26 | 44 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~1 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~3 | 0 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 其他信息 | 文字有新增/删除 | 0 | 0 | ~1 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):风险因素
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-09-18
OG&A rate, excluding fuel and Adjusted Items, bps increase (decrease)
●Identical sales, excluding fuel, increased 0.2% in the second quarter of 2026, compared to the second quarter of 2025. Sales growth was led by eCommerce, natural foods, meat and seafood, bakery and pharmacy sales, partially offset by the effects from the Inflation Reduction Act of 138 basis points,…
●On July 1, 2026, we announced that we had entered into an agreement and plan of merger pursuant to which we will acquire Giant Eagle, Inc. (“Giant Eagle”). The transaction is valued at approximately $1.65 billion, subject to customary purchase price adjustments, and consists of $1.25 billion in cas…
●Charges to OG&A of $56 million, $43 million net of tax, for transformation costs and $13 million, $9 million net of tax, for merger-related litigation charges (the “2026 Second Quarter OG&A Adjusted Items”).
Net earnings for the first two quarters of 2025 include the following, which we define as the “2025 Adjusted Items”:
相对上期删除的文字 · 来源:10-Q · 2026-06-26
●Identical sales, excluding fuel and the Labor Dispute, increased 1.0% in the first quarter of 2026, compared to the first quarter of 2025. Sales growth was led by performances in eCommerce, pharmacy, Fresh and Our Brands, partially offset by the effects from the Inflation Reduction Act of 130 basis…
●Charges to OG&A of $100 million, $77 million net of tax, for store closures; $15 million, $11 million net of tax, for merger-related litigation costs; $22 million, $17 million net of tax, for opioid settlement charges and vendor reserves and a credit to OG&A of $21 million, $16 million net of tax, …
Adjustment for opioid settlement charges and vendor reserves(9)
Executive stock compensation for a former executive income tax adjustment(9)
(2)The pre-tax adjustments for loss on investments were $14 and $19 in the first quarters of 2026 and 2025, respectively.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议